Case Report: Management of Chronic Scalp Psoriasis with Zoryve Foam in a 35-Year-Old Female
Patient Presentation
A 35-year-old female presented to our dermatology clinic in Katy, Texas, with a chief complaint of persistent dandruff accompanied by scalp itching and flaking. She described her symptoms as moderate in severity and had been struggling with the condition for several months.
The patient reported prior treatment with Clobetasol Solution, which initially improved her symptoms but lost effectiveness over time. She also used over-the-counter shampoos and apple cider vinegar, with minimal improvement.
Clinical Examination
A comprehensive dermatologic examination was performed, including evaluation of the scalp, ears, neck, and upper body. The patient appeared well-developed and well-nourished, alert, and in no acute distress.
On physical exam, the scalp showed erythematous, scaly plaques distributed over the left medial frontal and superior parietal scalp—consistent with scalp psoriasis. No signs of infection or folliculitis were present. A dermatoscope was used for detailed assessment.
Diagnosis
Scalp Psoriasis (L40.0) – Chronic, stable condition involving erythema, scaling, and plaques.
Treatment Plan
1. Medication: Zoryve Foam (Topical Roflumilast 0.3%)
The patient was prescribed Zoryve Foam, a once-daily topical phosphodiesterase-4 (PDE4) inhibitor designed for targeted control of psoriasis inflammation.
Instructions: Apply once daily to affected areas of the scalp, preferably at night.
Prescription Details:
Zoryve 0.3% Foam
Apply to scalp once daily
60g tube with 3 refills
Counseling and Expectations:
Skin Care: Use gentle, hydrating shampoos formulated with zinc pyrithione, tar, or selenium.
Expectations: Scalp psoriasis is chronic and often cycles between periods of remission and flare-ups. Stress, seasonal changes, and hair products can trigger flares.
When to Contact Office: If psoriasis worsens or fails to improve after several months of consistent use.
Side Effects: Mild local irritation or itching may occur but typically resolves with continued use.
The patient was educated on proper foam application and advised to maintain consistency with treatment. A follow-up visit in 3 months was scheduled to assess therapeutic response and tolerability.
Discussion
Scalp psoriasis is a chronic inflammatory skin condition characterized by thick, scaly plaques and redness of the scalp, often associated with itching, flaking, and embarrassment for patients.
Traditional treatments like topical corticosteroids or coal tar-based shampoos can lose effectiveness over time or cause irritation with long-term use.
The introduction of Zoryve Foam (roflumilast 0.3%) has provided a modern, non-steroidal option that targets the inflammatory cascade through PDE4 inhibition, reducing redness, scaling, and itch while minimizing steroid-related side effects.
At Village Dermatology in Katy and Houston, Texas, Dr. Reena Jogi customizes treatment regimens using advanced topical and systemic options to restore scalp health and patient confidence.
Conclusion
This case demonstrates successful management of chronic scalp psoriasis using Zoryve Foam, offering an effective, steroid-free alternative for patients with persistent flaking and itching. With proper counseling and adherence, the patient is expected to achieve improved scalp health and long-term control of symptoms.
